In this context we have found that the nuclear pore component Nup153 plays a key role in the aberrant estrogen response of prostate cancer, promoting the nuclear import of important determinants of transcription such as ERβ and eNOS which have been demonstrated to cooperate in driving the pathological gene signature. This evidence concerns the gene NUP153 and prostate cancer.